Celldex Therapeutics (CLDX) vs VolitionRX (VNRX)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 8, 2026.
Summary
Celldex Therapeutics is the larger company by market cap ($2.30 billion vs $6.6 million), about 348.9 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Head-to-head
| Metric | CLDX | VNRX |
|---|---|---|
| Share price | $29.30 | $0.2194 |
| Market cap | $2.30B | $6.60M |
| 1-day change | -3.71% | -2.92% |
| YTD return | +12.04% | — |
| 1-year return | +16.06% | — |
| 5-year return | -34.11% | — |
| EPS (TTM) | $-4.35 | $-3.80 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| Revenue (latest FY) | $1.54M | — |
| Revenue growth (YoY) | -77.99% | — |
| Net income (latest FY) | $-258.76M | — |
| Gross margin | 87.06% | — |
| Operating margin | -18599.81% | — |
| Net margin | -16748.03% | — |
| 52-week high | $45.14 | $12.80 |
| 52-week low | $22.10 | $0.217 |
| Distance from 52-week high | -35.09% | -98.29% |
| Analyst consensus | strong_buy | — |
| Avg. price target upside | +115.26% | — |
| Average volume | 1.27M | 8.46M |
| Shares outstanding | 78.53M | 30.06M |
| Employees | 198 | — |
| Sector | Health Care | Health Care |
| Industry | Biotechnology: In Vitro & In Vivo Diagnostic Substances | Biotechnology: In Vitro & In Vivo Diagnostic Substances |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- Celldex Therapeutics is about 348.9 times larger than VolitionRX by market value ($2.30B vs $6.60M).
About Celldex Therapeutics
CLDX stock →Celldex Therapeutics, Inc., a biopharmaceutical company, engages in developing therapeutic antibodies for patients with severe inflammatory, allergic, autoimmune, and other diseases. The company's drug candidates include monoclonal and bispecific antibodies designed to address mast cell mediated diseases for which available treatments are inadequate.
Health Care · Biotechnology: In Vitro & In Vivo Diagnostic Substances · 198 employees
CLDX vs VNRX FAQ
Which is bigger, Celldex Therapeutics or VolitionRX?
Celldex Therapeutics (CLDX) is larger, with a market capitalization of $2.30B compared with $6.60M for VolitionRX (VNRX).
Are Celldex Therapeutics and VolitionRX in the same industry?
Yes. Both are classified in the Biotechnology: In Vitro & In Vivo Diagnostic Substances industry within the Health Care sector.